Most popular posts
- What makes great boards great
- The fate of control
- March Madness and the availability heuristic
- When business promotes honesty
- Due diligence: mine, yours, and ours
- Alligator Alley and the Flagler (?!) Dolphins
- Untangling skill and luck in sports
- The Southeastern Growth Corridors
- Dead cats and iterative collaboration
- Empirical evidence: power corrupts?
- A startup culture poses unique ethical challenges
- Warren Buffett and after-tax returns
- Is the secret to national prosperity large corporations or start-ups?
- This is the disclosure gap worrying the SEC?
- "We challenged the dogma, and it was incorrect"
- Our column in the Tampa Bay Business Journal
- Our letter in the Wall Street Journal
Other sites we recommend
PaceMate™ Closes Series A Financing to Accelerate Growth
PaceMate™, the leading digital healthcare company in compliant cardiac data management, is pleased to announce a recent $8 million Series A investment led by Ballast Point Ventures. PaceMate™’s fully automated, bidirectional EHR-integrated platform—PaceMate™LIVE—is a comprehensive, cloud-native cardiac data management solution, delivering round-the-clock remote monitoring service, customized alerts and automated billing codes. PaceMate™ will use this investment from Ballast Point to expand market reach for PaceMate™LIVE and enable more cardiac device clinics to care for their patients efficiently with better outcomes.
“Ballast Point’s funding propels PaceMate™’s presence in the cardiac data space, making it possible to extend our reach in the cardiac monitoring market and offer our platform to additional hospital systems and device clinics”
Ballast Point Ventures, headquartered in Tampa, Florida, is a later-stage venture capital and growth equity fund founded in 2002 to provide expansion capital for rapidly growing, privately owned companies in the healthcare, software and technology-enabled business services industries. PaceMate™ is the first investment out of Ballast Point Ventures IV. “PaceMate™’s proprietary technology platform and monitoring services allow clients to improve the quality of care while leveraging existing technology infrastructure and seamlessly fitting into clinic workflows,” said Matt Rice, Partner at Ballast Point Ventures. “We’re excited to partner with Tripp Higgins and his team as they continue to expand the reach of this unique and innovative solution.”
“Ballast Point’s funding propels PaceMate™’s presence in the cardiac data space, making it possible to extend our reach in the cardiac monitoring market and offer our platform to additional hospital systems and device clinics,” said Tripp Higgins, CEO of PaceMate™. “We give our customers unique digital healthcare opportunities and connect them with the most essential clinical information from their patients’ EHRs in real time. With this investment, implementation of our platform can happen faster, and more cardiology clients can take advantage of our unmatched data capabilities.”
PaceMate™ was founded in 2015 by cardiac rhythm management industry professionals who experienced firsthand the overwhelming amount of device data inundating clinicians on a daily basis. In answer to this ever-increasing health data problem, the PaceMate™ team developed innovative technology to streamline the device clinic, improve workflow, reduce medical errors and take better care of patients. Today, PaceMate™LIVE is a best-in-class, cloud-native software+service solution for real-time cardiac device management—supporting clinics 24.7.365. Device-generated data automatically uploads to our vendor-neutral platform for immediate review—reporting clinically actionable alerts with complete, bi-directional EHR integration. Meet us at the intersection of human intelligence, innovative data management and compassionate healthcare—where we never miss a beat.™